Drawing for ARC

USPTO serial 87574584

ARC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SETTLES LEWIS, SHAILA E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammatory disease; pharmaceutical preparations, namely, bi-specific fusion proteins for medical diagnostic purposes; biological preparations for the treatment of inflammatory disease; pharmaceutical products for the prevention of cancer and the prevention and treatment of inflammatory disease; synthetic peptides for the treatment of inflammatory disease; vaccine preparations; none of the foregoing goods are for veterinary purposes, and none of the foregoing in connection with either medicated topical creams for treating radiation dermatitis or medicated skin care preparations for protecting skinACTIVE
042Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and inflammatory disease; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, development of pharmaceutical preparations in the form of cancer immunotherapy proteins for use in manufacturing therapeutics; None of the foregoing services are for veterinary purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 3, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 3, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2022EX5GSOU EXTENSION 5 GRANTED
Aug 18, 2022EXT5SOU EXTENSION 5 FILED
Aug 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2022EX4GSOU EXTENSION 4 GRANTED
Feb 23, 2022EXT4SOU EXTENSION 4 FILED
Feb 23, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2021EX3GSOU EXTENSION 3 GRANTED
Aug 17, 2021EXT3SOU EXTENSION 3 FILED
Aug 17, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 10, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2021EX2GSOU EXTENSION 2 GRANTED
Feb 18, 2021EXT2SOU EXTENSION 2 FILED
Feb 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 7, 2020NOACCORRECTED NOA E-MAILED
Oct 6, 2020DPCCDIVISIONAL PROCESSING COMPLETE
Oct 5, 2020IROARESPONSE TO ITU OFFICE ACTION ENTERED
Oct 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2020INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Sep 28, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 11, 2020DRRRDIVISIONAL REQUEST RECEIVED
Sep 11, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED
Aug 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2020EX1GSOU EXTENSION 1 GRANTED
Aug 24, 2020EXT1SOU EXTENSION 1 FILED
Aug 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 25, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 10, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS
Jan 10, 2020OP.TOPPOSITION TERMINATED NO. 999999
Jan 10, 2020OP.DOPPOSITION DISMISSED NO. 999999
May 17, 2019OP.IOPPOSITION INSTITUTED NO. 999999
Dec 19, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Nov 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2018XAECEXAMINER'S AMENDMENT ENTERED
Sep 27, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2018GNEAEXAMINERS AMENDMENT E-MAILED
Sep 27, 2018CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 31, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 28, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2017DOCKASSIGNED TO EXAMINER
Aug 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance